Articles

Infectious diseases are the second leading cause of death worldwide, and new infectious diseases continue to emerge. Infants and children are among the most susceptible.

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.

Deb Bowes from Women in Bio discusses plans for the upcoming BIO International Convention, the critical role of women’s leadership in biotechnology, and why she is personally committed to Women in Bio and its mission.

A report on the benefits for health care, nutrition, the environment, and animal welfare.

“I’ve never been a farmer,” Bill Gates confessed at The Chicago Council’s Symposium on Global Agriculture and Food Security. “Until recently, I rarely set foot on a farm.”

All programs at the BIO World Congress on Industrial Biotechnology and Bioprocessing are open to attendance by members of the media. Complimentary media registration is available to editors and reporters with valid press credentials working full time for print, broadcast or web publications.

Some of the most pressing challenges for the advent of personalized medicine relate to the reimbursement of novel diagnostics. Reimbursement policies must reflect the potential benefit that novel diagnostics can bring to patients and the healthcare system. This value proposition can be realized through reimbursement policy reforms that provide a clear and consistent pathway to obtain affirmative coverage, appropriate and timely coding, and market-based payment for diagnostic tests. BIO recommends that the following reforms be made to diagnostic reimbursement policy.

Dr. Jay Siegel of  Johnson & Johnson Pharmaceutical Research & Development  and Janelle Curtis from the  Biotechnology Institute  discuss this year’s International BioGENEius Challenge.

The advanced biofuel industry can reduce reliance on oil and create green jobs; diverse federal programs are necessary to help producers secure financing for construction of projects. The Biotechnology Industry Organization (BIO) today joined 34 other companies and trade associations to ask leaders of the House Ways and Means Committee to include the language of H.R. 5142, the Grow a Renewable Energy Economy Now – Jumpstart Other Biofuels (GREEN JOB) Act of 2010, in the next appropriate revenue vehicle considered by the House.

The Biotechnology Industry Organization (BIO) today thanked Agriculture Secretary Tom Vilsack and Energy Secretary Steven Chu on the announcement of Biomass Research And Development Initiative grants and the establishment of a Biomass Crop Assistance Plan project area. BIO congratulated member companies Cellana LLC of Hawaii and Metabolix Inc. of Massachusetts on receiving awarded grants.

The number of Americans diagnosed with diabetes — the seventh leading cause of death in the U.S. — has risen by epidemic proportions. In addition, the disease is estimated to affect 435 million people worldwide by 2030. BIO and the Juvenile Diabetes Research Foundation will feature a two-day diabetes forum for the first time at the 2011 BIO International Convention in Washington, DC. The sessions will showcase the latest research in novel therapies, vaccines, and biomarkers.